Form 4 for CDNA CareDx, Inc.
Accepted 2024-05-01 00:00:00 ET · period of report 2024-04-29 · accession 0000950170-24-051337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-01 | 2024-04-29 | CDNA | Maag Peter | Dir | M - OptEx | $5.27 | +13.3K | 327.3K | +4% | +$70.0K |
| D | 2024-05-01 | 2024-04-29 | CDNA | Maag Peter | Dir | M - OptEx | $5.27 | -13.3K | 0 | -100% | -$70.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-29 | M | A | 13,281 | $5.27 | 327,264 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-04-29 | M | D | 13,281 | $5.27 | 0 | D | $5.27 · — to 2026-01-22 | 13,281 Common Stock | (F1) The option was originally granted on January 22, 2016 and, as of January 22, 2020, was fully vested. |